Free Trial

Invesco Ltd. Invests $19.07 Million in Stevanato Group S.p.A. $STVN

Stevanato Group logo with Medical background

Key Points

  • Invesco Ltd. invested approximately $19.07 million in Stevanato Group S.p.A. by acquiring 933,964 shares, increasing its stake to 0.31% as per the latest SEC filing.
  • Several other large investors also adjusted their stakes in Stevanato Group, with notable increases from Wells Fargo (680.3%) and Tower Research Capital (202.8%) in the fourth quarter.
  • Analysts have given Stevanato Group a largely positive outlook, with one analyst rating it as a Strong Buy and a cumulative average rating of "Moderate Buy."
  • Want stock alerts on Stevanato Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Invesco Ltd. bought a new stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 933,964 shares of the company's stock, valued at approximately $19,072,000. Invesco Ltd. owned 0.31% of Stevanato Group as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in STVN. Wells Fargo & Company MN raised its stake in Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock valued at $71,000 after purchasing an additional 2,830 shares during the period. Raymond James Financial Inc. acquired a new stake in Stevanato Group during the 4th quarter valued at $5,754,000. Tower Research Capital LLC TRC raised its stake in Stevanato Group by 202.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock valued at $162,000 after purchasing an additional 4,965 shares during the period. Hancock Whitney Corp acquired a new stake in Stevanato Group during the 4th quarter valued at $239,000. Finally, Johnson Financial Group Inc. acquired a new stake in Stevanato Group during the 4th quarter valued at $41,000.

Analysts Set New Price Targets

Separately, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy".

View Our Latest Stock Report on STVN

Stevanato Group Trading Down 0.5%

Shares of NYSE:STVN opened at €22.79 on Friday. The firm has a fifty day moving average of €24.36 and a two-hundred day moving average of €22.49. The firm has a market capitalization of $6.90 billion, a P/E ratio of 42.20, a price-to-earnings-growth ratio of 2.16 and a beta of 0.55. Stevanato Group S.p.A. has a 12-month low of €17.12 and a 12-month high of €28.00. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25.

Stevanato Group Company Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Further Reading

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN - Free Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines